Chemed CEO sells 2,000 shares at $541 average

CHEMED CORP (CHE) reported that president and CEO Kevin J. McNamara sold 2,000 shares of Chemed capital stock on 2026-08-21 in an open market or private transaction.

Rhea-AI Filing Summary

CHEMED CORP (CHE) reported that president and CEO Kevin J. McNamara sold 2,000 shares of Chemed capital stock on 2026-08-21 in an open market or private transaction. The weighted average sale price was reported as $541.16 per share, with individual trade prices ranging from $539.62 to $542.53. After this transaction, McNamara directly held 70,418 shares of Chemed capital stock. The company notes that full trade-by-trade pricing details are available upon request.

Insider Trade Summary

Net Seller: 2,000 shares

Net Sell 1 txn

Insider MCNAMARA KEVIN J

Role president and CEO

Sold 2,000 shs ($1.08M)

Type	Security	Shares	Price	Value
Sale	Capital Stock F1	2,000	$541.16	$1.08M

Holdings After Transaction: Capital Stock — 70,418 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.62 to $542.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

Key Figures

Shares sold: 2,000 shares Weighted average sale price: $541.16 per share Sale price range: $539.62 to $542.53 per share +2 more

5 metrics

Shares sold 2,000 shares Capital Stock sold by Kevin J. McNamara on 2026-08-21

Weighted average sale price $541.16 per share Reported in Column 4 for the 2,000-share sale

Sale price range $539.62 to $542.53 per share Multiple transactions comprising the reported sale

Shares held after transaction 70,418 shares Direct holdings of Kevin J. McNamara following the sale

Net shares sold 2,000 shares Net change in buy/sell activity in this Form 4

Key Terms

weighted average price, open market or private transaction, Capital Stock

3 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

Capital Stock financial

"security_title: Capital Stock"

Capital stock is the total set of shares that represent ownership in a company, including different classes such as common and preferred stock. Think of it as the number and types of slices in a company’s ownership pie: it matters to investors because it determines voting power, entitlement to dividends, and how a company’s value is divided per share, so changes in capital stock can dilute holdings or alter per‑share metrics.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CHEMED CORP (CHE) report for Kevin J. McNamara?

Kevin J. McNamara, president and CEO, reported a sale of 2,000 shares of Chemed capital stock on 2026-08-21 in an open market or private transaction.

At what price did Kevin J. McNamara sell CHE (Chemed) shares?

The reported weighted average sale price was $541.16 per share, with individual trades executed at prices ranging from $539.62 to $542.53.

How many CHEMED CORP (CHE) shares does Kevin J. McNamara hold after this sale?

Following the reported sale, Kevin J. McNamara directly held 70,418 shares of Chemed capital stock.

Was the 2026-08-21 CHE (CHEMED CORP) insider transaction a purchase or a sale?

The 2026-08-21 insider transaction by Kevin J. McNamara was a sale of 2,000 shares of Chemed capital stock, classified under transaction code S (sale in open market or private transaction).

Is detailed price information for Kevin J. McNamara’s CHE share sale available?

Yes. The filing states that the 2,000 shares were sold in multiple transactions between $539.62 and $542.53, and that full information on the number of shares sold at each separate price is available upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/24/2026 - 09:50 AM EDT Accepted by SEC EDGAR 08/24/2026 - 09:49 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	president and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	08/21/2026		S		2,000	D	$541.16(1)	70,418	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.62 to $542.53. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

	Kevin J. McNamara	08/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)